Ledger.Open graph →
SEC Form D · filed June 3, 2020

NERVGEN PHARMA CORP

Offering
$650K
Sold
$285K
Exemption
Rule 506(b)
Industry
Other
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

William Adams · Vancouver, British Columbia, CanadaExecMichael Abrams · Vanouver, British Columbia, CanadaDirectorPaul Brennan · Vancouver, British Columbia, CanadaExec · DirectorBrian J. Bayley · Vancouver, British Columbia, CanadaDirectorHarold J. Punnett · Vancouver, British Columbia, CanadaDirectorBill Radvak · Vancouver, British Columbia, CanadaDirectorJacob L. Block · Grove City, OHExecRichard R. Halderman · Zionsville, INDirectorRoger Tichenor · Sarasota, FLDirectorRod W. Saddington · DALLAS, TXExec · DirectorBruce Cassidy · Sarasota, FLDirectorZarrell R. Gray · Zionsville, INDirectorLloyd Mackenzie · Vancouver, British Columbia, CanadaExecAmy Franke · Vancouver, British Columbia, CanadaExecAndrew Hemingway · Bristol, NHDirectorMLG Fund Manager LLC · Brookfield, WIDirectorYuriy Gordiyenko · Brooklyn, NYDirectorMikhail Zlotnik · Brooklyn, NYDirectorYuriy Novodvorskiy · Brooklyn, NYExec · DirectorAlina Trigub · Brooklyn, NYExecLloyd Mackenzie · Vancouver, British Columbia, CanadaExecAmy Franke · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗